Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer

<div>(a) Plasma mSEPT9 status conversion after primary tumor resection in CRC patients. (b) Follow-up of a representative CRC case (sample number ID: 7) with remaining positive mSEPT9 after surgery. (a) P: positive; N: negative. (b) +: positive; −: negative; CNS: central nervous system; CEA: ng/mL, boldface represents positive.</div>

Disease Markers

fig2

Figure 2

Figure 2: Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer 